tadalafil has been researched along with alprostadil in 14 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 7,136 | 864 | 761 |
| Protein | Taxonomy | tadalafil (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C | 1 |
| Gaines, KK | 1 |
| Hatzichristou, DG; Hatzimouratidis, K | 1 |
| Agarwal, A; Nandipati, KC; Raina, R; Zippe, CD | 1 |
| Gopalakrishanan, G; Tharyan, P | 1 |
| Calogero, AE; Cannizzaro, MA; Condorelli, R; La Vignera, S; Noto, Z; Vicari, E | 1 |
| Katz, A | 1 |
| Eisenhardt, SU; Fritsche, HM; Iblher, N; Katzenwadel, A; Lampert, F; Penna, V; Stark, GB | 1 |
| Barret, E; Cathala, N; Cathelineau, X; Djavan, B; Galiano, M; Giuliano, F; Jaffe, J; Kazzazi, A; Mombet, A; Prapotnich, D; Rozet, F; Sanchez-Salas, R; Vallancien, G | 1 |
| Brock, G; Burnett, A; Ghanem, H; Giuliano, F; Glina, S; Hellstrom, W; Martin-Morales, A; Porst, H; Salonia, A; Sharlip, I | 1 |
| Giessing, M; Neumann, NJ; Thierling, U; Uche-Holub, E | 1 |
| Comerma-Steffensen, S; Knudsen, JS; Munk, NE; Simonsen, U | 1 |
| Forootanfar, H; Hamzehnejadi, M; Homayouni, F; Jahani, Z; Langarizadeh, MA; Rezaei, M; Tavakoli, MR | 1 |
8 review(s) available for tadalafil and alprostadil
| Article | Year |
|---|---|
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combinations; Erectile Dysfunction; Humans; Imidazoles; Injections; Male; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamine Agonists; Drug Combinations; Enzyme Inhibitors; Erectile Dysfunction; Humans; Imidazoles; Male; Papaverine; Patient Satisfaction; Penile Prosthesis; Penis; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2005 |
Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.
Topics: Administration, Oral; Aged; Algorithms; Alprostadil; Carbolines; Combined Modality Therapy; Drug Therapy, Combination; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Penile Prosthesis; Phosphodiesterase Inhibitors; Piperazines; Practice Guidelines as Topic; Prostatectomy; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2006 |
Erectile dysfunction.
Topics: Adult; Alprostadil; Apomorphine; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Penile Erection; Penile Prosthesis; Piperazines; Purines; Sex Counseling; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine | 2006 |
Penile rehabilitation.
Topics: Alprostadil; Carbolines; Causality; Clinical Protocols; Erectile Dysfunction; Fibrosis; Humans; Male; Nurse's Role; Penile Prosthesis; Penis; Phosphodiesterase Inhibitors; Piperazines; Postoperative Care; Prostatectomy; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Vasodilator Agents | 2009 |
SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alprostadil; Carbolines; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Piperazines; Pyrimidines; Risk Factors; Sulfonamides; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Yohimbine | 2013 |
Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.
Topics: Administration, Oral; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate; Tadalafil; Treatment Failure; Treatment Outcome; Vasodilator Agents | 2019 |
Prostaglandins as a Topical Therapy for Erectile Dysfunction: A Comprehensive Review.
Topics: Alprostadil; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Prostaglandins; Sildenafil Citrate; Tadalafil; Vardenafil Dihydrochloride | 2022 |
2 trial(s) available for tadalafil and alprostadil
| Article | Year |
|---|---|
Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
Topics: Aged; Alprostadil; Arteries; Attitude to Health; Blood Flow Velocity; Carbolines; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Erectile Dysfunction; Humans; Injections; Luteinizing Hormone; Male; Middle Aged; Nitric Oxide; Penis; Prolactin; Surveys and Questionnaires; Tadalafil; Testosterone; Treatment Outcome; Vasodilator Agents | 2006 |
Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.
Topics: Adult; Aged; Alprostadil; Carbolines; Coitus; Erectile Dysfunction; Humans; Laparoscopy; Male; Medication Adherence; Middle Aged; Organ Sparing Treatments; Orgasm; Penile Erection; Peripheral Nerves; Phosphodiesterase 5 Inhibitors; Postoperative Care; Prostate; Prostatectomy; Prostatic Neoplasms; Severity of Illness Index; Surveys and Questionnaires; Tadalafil; Vasodilator Agents | 2012 |
4 other study(ies) available for tadalafil and alprostadil
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Coming attractions! New medications on the horizon for erectile dysfunction.
Topics: Alprostadil; Apomorphine; Carbolines; Drug Approval; Erectile Dysfunction; Genetic Therapy; Global Health; Humans; Male; Phosphodiesterase Inhibitors; Tadalafil; United States; United States Food and Drug Administration | 2003 |
Refinements in reconstruction of penile skin loss using intra-operative prostaglandin injections, postoperative tadalafil application and negative pressure dressings.
Topics: Adult; Aged; Alprostadil; Carbolines; Fournier Gangrene; Graft Rejection; Graft Survival; Humans; Injections, Intralesional; Intraoperative Care; Male; Negative-Pressure Wound Therapy; Penile Erection; Penis; Plastic Surgery Procedures; Postoperative Care; Recovery of Function; Risk Assessment; Sampling Studies; Skin Transplantation; Tadalafil; Vasodilator Agents; Wound Healing | 2012 |
[Intracavernous injection: a treatment modality for erectile dysfunction].
Topics: Alprostadil; Carbolines; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Penis; Piperazines; Purines; Self Administration; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Vasodilator Agents | 2013 |